Matches 1 - 50 out of 98 1 2 >

AcclaimIP-ad

Match Document Document Title
US20140193460 HERPES VIRUS VACCINE AND METHODS OF USE  
Provided herein are, inter alia, vaccines and methods of using the same for the treatment or prevention of Herpesvirus infections.
US20140322268 SYNTHETIC GLUCOPYRANOSYL LIPID ADJUVANTS  
Compounds, particularly, glucopyranosyl lipid adjuvant (GLA) compounds, having the following structure (I) are provided: or a pharmaceutically acceptable salt thereof, wherein L1, L2, L3, L4, L5,...
US20100310602 SYNTHETIC GLUCOPYRANOSYL LIPID ADJUVANTS  
Compounds, particularly, glucopyranosyl lipid adjuvant (GLA) compounds, having the following structure (I) are provided: or a pharmaceutically acceptable salt thereof, wherein L1, L2, L3, L4, L5,...
US20140348875 KOI HERPESVIRUS VACCINE  
The present invention relates to a recombinant Koi herpesvirus (KHV), methods for the production of such KHV, cells comprising such KHV and the use of such KHV as vector and in vaccines for the...
US20120034262 Bovine Herpes Virus-1 Compositions, Vaccines and Methods  
The disclosure relates generally to the treatment or prevention of disease in cattle. More particularly, the invention is directed to the production and use of modified bovine herpesvirus 1...
US20110223195 COMPOSITION COMPRISING CHITOSAN FOR OCULAR ADMINISTRATION OF VACCINE(S) TO AVIANS  
The invention relates to vaccine compositions comprising chitosan and a vaccine which are administered to avian species via the ocular route, and methods or programs of vaccination including use...
US20130202638 VACCINE AGAINST BETA-HERPESVIRUS INFECTION AND USE THEREOF  
The present invention is related to a beta-herpesvirus, wherein the beta-herpesvirus is spread-deficient.
US20140065100 Compositions and Methods for Cancer Immunotherapy  
The invention relates to immunotherapeutic compounds and to methods for stimulating an immune response in a subject individual at risk for developing cancer, diagnosed with a cancer, in treatment...
US20140271710 LIQUID STABLE BOVINE VIRUS VACCINES  
The present invention discloses liquid stable bovine vaccines that comprise a live attenuated virus, in sucrose, arginine, and methionine. The present invention also discloses the manufacture of...
US20110150940 DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION  
This invention provides a dry powder composition for poultry vaccination via inhalation comprising an effective amount of a poultry vaccine agent, and a supporting amount of carriers for said...
US20140271709 BOVINE VIRUS VACCINES THAT ARE LIQUID STABLE  
The present invention discloses liquid stable bovine vaccines that comprise a live attenuated virus, and a sugar alcohol. The present invention also discloses the manufacture of such vaccines and...
US20120141465 VIRUS VACCINATION AND TREATMENT METHODS WITH OX40 AGONIST COMPOSITIONS  
The invention relates to compositions and methods that employ OX40 (CD134), a TNFR superfamily protein, agonists. The invention includes among other things administering an OX40 agonist alone or...
US20130337009 CHIMERIC DNA VACCINE COMPOSITIONS AND METHODS OF USE  
The present invention relates to compositions and methods for the prevention and treatment of infectious diseases. In particular, the invention relates to stimulating an immune response in a...
US20130302351 ANTAGONISM OF THE VIP SIGNALING PATHWAY  
The disclosure relates to inhibition of the VIP signaling pathway. In certain embodiments, the disclosure relates to methods of treating or preventing a viral infection comprising administering a...
US20110091496 METHODS AND COMPOSITIONS FOR THE DELIVERY OF VACCINES TO DISRUPTED EPITHELIUM  
The invention features immunogenic compositions and methods useful for eliciting an immune response. In preferred embodiments, papillomavirus or adenovirus vectors are used to elicit exceptionally...
US20120269854 Method of Enhancing KSHV LANA1 Immunogenicity  
An immunogenically-enhanced Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (“KSHV LANA1”) polypeptide and related methods of eliciting an immune response to KSHV LANA1...
US20140255447 PRODUCTION OF AVIAN EMBRYO CELLS  
The present invention relates to compositions and methods for preparing cells from avian embryos. The invention also relates to cultures of such cells and the uses thereof, particularly for...
US20120164169 BOVINE HERPESVIRUS VACCINE  
The present invention relates to mutant Bovine Herpesvirus 4 genomes, mutant Bovine Herpesvirus 4 viruses, to mutant Bovine Herpesvirus 4 genomes and viruses carrying a heterologous DNA sequence,...
US20130034585 Bovine Herpes Virus Vaccine With Multiple Mutations  
A BHV-1 mutant virus has been made that incorporates into a single virus two or more deletions in one or more of three genes—glycoprotein N, glycoprotein E and Us9. Specifically, a BHV-1...
US20120076823 Vector  
The present invention relates to a herpes virus vector which comprises a modified genomic sequence encoding a microRNA (miRNA) against a target sequence. The herpes virus vector may be used as or...
US20130224244 VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE (CIRD)  
A vaccine composition for vaccinating dogs comprising any one or more of (a) an agent capable of raising an immune response against Streptococcus equi sub species zooepidemicus in a dog, (b) an...
US20120064151 ENHANCED IMMUNE RESPONSE IN AVIAN SPECIES  
The present invention relates to a method of immune activation which is effective for eliciting a non-antigen-specific immune response in a member of the avian species. The method is particularly...
US20110177120 MYCOBACTERIUM TUBERCULOSIS VACCINE  
The present invention relates to the use of live mycobacterium of the M. tuberculosis complex for preparing a medicament, wherein the function of the zmp1-gene is inactivated, pharmaceutical...
US20140141043 COMPOSITIONS, VECTORS, KITS, AND METHODS FOR IMMUNIZING AGAINST AVIAN INFECTIOUS BRONCHITIS VIRUS  
Disclosed are compositions, vectors, kits, and methods for inducing an immune response against avian infectious bronchitis virus (IBV). In particular, the compositions, vectors, kits, and methods...
US20110287089 USE OF A SACCHAROMYCES CEREVISIAE MITOCHONDRIAL NUCLEIC ACIDS FRACTION FOR IMMUNE STIMULATION  
The present invention relates to the use of a Saccharomyces cerevisiae mitochondrial nucleic acids fraction and an antigen for the preparation of a pharmaceutical composition intended to orient...
US20120237544 BACTERIAL SPORE HAVING THERAPEUTIC AGENT ADSORBED ON ITS SURFACE  
The present invention relates to a method of coating a spore with one or more therapeutic agents. The present invention also relates to a coated spore obtained by the method of the present...
US20130195918 Equine Herpesvirus 1 Vaccine and Vector and Uses Thereof  
We have constructed a mutant EHV-1 that is lacking the entire 12.7 kbp IR segment of the viral genome and found the mutant EHV-1 to be replication competent, to have the ability to replicate in...
US20110002961 Interleukin 12 paracrine gene delivery enhanced CTL immunotherapy  
A method of treating a patient with a disease wherein the patient contains diseased cells which cells contain antigens for identification and which cells are capable of presenting at least part of...
US20100330122 VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES (VLPs) AND ANTIGENS  
The present invention discloses novel Varicella Zoster Virus (VZV) virus-like particles (VLPs) comprising glycoprotein E of VZV. The invention also discloses vaccine formulations of the VZV-VLPs...
US20100266629 Cattle Reproductive Disease Vaccines  
The present invention relates to combination vaccines and methods for treating or preventing diseases or disorders in an animal caused by infection by Bovine Viral Diarrhea Virus (BVDV) Types 1...
US20110212123 Immunogenic Substances Comprising a Polyinosinic Acid - Polycytidilic Acid Based Adjuvant  
The present invention provides a polynucleotide adjuvant (PICKCa) composition and methods of use in eliciting an immune response, in particular a mucosal immune response. The polynucleotide...
US20110182847 USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS  
Improved (safer and more effective) methods of therapy using TNF-R agonists, e.g., CD40 agonists are provided. These methods provide for the addition of an amount of a type 1 interferon and/or a...
US20110236419 RECOMBINANT CDV COMPOSITIONS AND USES THEREOF  
The present invention provides vectors that contain and express in vivo or in vitro CDV polypeptides or antigens that elicit an immune response in animal against CDV, compositions comprising said...
US20110033499 ANTI-VIRAL NUTRACEUTICAL  
A method for the prophylaxis or treatment of a viral infection in a mammal is described. The method comprises administering to the mammal an effective amount of a mollusc hemocyanin and/or an...
US20100272752 VACCINE FOR VIRUSES THAT CAUSE PERSISTENT OR LATENT INFECTIONS  
The invention is in general directed to methods and compositions for preventing or treating infections by viruses involved in persistent and/or latent infections. The methods and compositions are...
US20100150958 Methods and Compositions for Use of a Coccidiosis Vaccine  
The invention relates to new vaccine compositions for vaccinating birds.
US20140037716 IMMUNOGENIC COMPOSITION FOR IMMUNE SYSTEM MODULATION AND USE THEREOF, METHOD FOR TREATING AND PREVENTING DISEASES, METHOD FOR INDUCING CELL REGENERATION AND METHOD FOR RESTORING IMMUNE RESPONSE  
The present invention relates to immunogenic compositions for modulating the immune system, comprising a therapeutically effective quantity of two or more immuno-active antigenic agents with...
US20090041852 DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION  
This invention provides a dry powder composition for poultry vaccination via inhalation comprising an effective amount of a poultry vaccine agent, and a supporting amount of carriers for said...
US20090060947 Immunological compositions  
The disclosure relates to immunological compositions for vaccinating human beings against infection by the Human Immunodeficiency Virus (HIV).
US20070172490 Leukocyte stimulation matrix  
The present invention relates to a leukocyte stimulation matrix for the simulation of leukocytes and/or the induction of an immunological tolerance comprising a) at least one carrier, b) a soluble...
US20080241187 STABILIZATION OF VIRAL COMPOSITIONS  
This invention concerns stabilized virus compositions, preferably a herpesvirus which may be an attenuated or genetically modified herpes simplex virus or varicella zoster virus, and a method of...
US20080118530 Modulation of Replicative Fitness By Deoptimization of Synonymous Codons  
Methods of producing a pathogen with reduced replicative fitness are disclosed, as are attenuated pathogens produced using the methods. In particular examples, the method includes deoptimizing one...
US20110268762 IMMUNIZATION OF AVIANS BY MUCOSAL ADMINISTRATION OF NON-REPLICATING VECTORED VACCINES  
The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the invention relates to mucosal administration via aerosol spray to avians of...
US20100104599 Compositions and Methods For Enhancing Immune System of Felines  
Compositions and methods useful to enhance the development of the immune system of a growing animal are disclosed.
US20090110697 INACTIVATED BOVINE HERPES VIRUS-1 AND METHODS  
This invention related to a method of immunizing cattle to reduce the effects of infection by bovine herpes virus 1, including abortion and stillbirth, by administering inactivated bovine herpes...
US20100172937 ENVELOPED VIRUS NEUTRALIZING COMPOUNDS  
Methods for reducing infectivity by providing an enveloped virus neutralizing compound (EVNC) are provided. Methods of preparing a vaccine, vaccine formulations, and methods of immunizing a...
US20100047279 IMMUNOLOGICAL COMPOSITION  
The present invention relates to immunological compositions comprising sulpholipo-cyclodextrin (SL-CD) and, saponin or Quil A, and optionally at least one antigen. The invention relates to methods...
US20100003279 VACCINE FOR IN OVO INOCULATION  
A purpose of the present invention is to provide a vaccine for in ovo inoculation effective for prevention of any fowl viral diseases. A fowl vaccine for in ovo inoculation with high efficacy in...
US20120269848 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFECTION  
This invention relates to cholesterol-sequestering agents and methods of using cholesterol-sequestering agents to treat or prevent infection. The compositions of the invention can be used in vitro...
US20080220018 VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE(CIRD)  
A vaccine composition for vaccinating dogs comprising any one or more of (a) an agent capable of raising an immune response against Streptococcus equi sub species zooepidemicus in a dog, (b) an...
Matches 1 - 50 out of 98 1 2 >